Research indicates that viral delivery of Neurotrophic Factor‐α1/Carboxypeptidase E (NF‐α1/CPE) in the hippocampus prevented the later development of cognitive deficits in mice, supporting the promise of gene therapy for AD [256]. The gene discussed is CPE; the disease is Alzheimer disease.